ArticleCancers2021

Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.

Michela Verzè et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.